Flow cytometry analysis further revealed that downstream effectors of TLR9, including IRF3, MyD88, and TRAF3, were elevated in all of the sepsis patients compared with the normal donors (Figure 6F, 6G & 6H), and was correlated with improved prognosis in patients with sepsis. The gene discussed is TLR9; the disease is Sepsis.